DANON URI 4
4 · BIOCANCELL THERAPEUTICS INC. · Filed Jan 5, 2010
Insider Transaction Report
Form 4
BIOCANCELL THERAPEUTICS INC.BICL.TA
DANON URI
Chief Executive Officer
Transactions
- Award
Option to Purchase Common Stock
2009-12-31+450,000→ 450,000 totalExp: 2019-12-31→ Common Stock, par value $0.01 (450,000 underlying)
Footnotes (2)
- [F1]The exercise price is 3.18 NIS per share.
- [F2]80,000 options shall vest and be exercisable immediately, and 23,125 options shall vest and be exercisable at the end of 16 consecutive calendar quarters commencing December 31, 2009, provided, however, that the vesting of some options will be accelerated if pre-set milestones are achieved by pre-set dates.